Looking to publish in Molecular Diagnosis & Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowMolecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine. The journal publishes reviews and original research articles focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on companion diagnostic and therapeutic products, pharmacogenomic data for drug development, and therapeutic decision making.
Looking to publish in Molecular Diagnosis & Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Molecular Diagnosis & Therapy accepts the following article types. Click on an article type to view submission instructions.
Review Article
Systematic Review
Original Research
Letter To The Editor
Recent Publications
Therapeutic Strategies Targeting the Molecular Pathogenesis of Myotonic Dystrophy Type 1: Current Status and Future Directions
Mohamed Chahine, Vamsi Krishna Murthy Ginjupalli, Dominic Jauvin, Mohamed Boutjdir
Beyond Binary FISH Results: Targeted NGS Provides Deeper Characterization of MYC and Broader Genomic Alterations in DLBCL
Mariana Bastos Oreiro, Sara Fernández de Córdoba Oñate, Ismael de la Iglesia San Sebastián, Francisco Díaz-Crespo, María Chicano Lavilla, Juan Carlos Triviño, Raquel Fernández González, Miguel López-Esteban, Marina Gómez-Llobel, Paula Fernández Caldas, Pablo Silva, Javier Menárguez, Ramón García Sanz, Ismael Buño, Carolina Martínez Laperche
From Gene to Hope: Rett Syndrome and the Rise of Molecular Therapies
Yoann Leblay, Marie-Solenne Felix, Jean-Christophe Roux, Nicolas Panayotis
The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance
Klára Baďurová, Veronika Kapustová, Jana Kotulová, Vítězslav Brinsa, Lenka Piherová, Václav Janoušek, Michal Pohludka, Michal Richtář, Tomáš Jelínek, Roman Hájek, Zuzana Chyra, Tereza Ševčíková
Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors
Masahiro Okada, Satoru Yamasaki, Go R. Sato, Kanako Shimizu, Shin-ichiro Fujii
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 7 days.
Reformat to Molecular Diagnosis & Therapy using Livewrite PremiumIs a cover letter required?
A submission letter is referenced for reviewer suggestions, and the corresponding author should mention any unpublished material included in the manuscript in a cover letter to the Editor.
Reformat to Molecular Diagnosis & Therapy using Livewrite PremiumWhat are the publication costs?
No charge for the traditional subscription-based publishing route; optional open access publication is available for accepted articles.
Reformat to Molecular Diagnosis & Therapy using Livewrite Premium